ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
ResMed (RMD) Tops Q1 EPS by 6c, Revenues Beat
October 24, 2019 4:09 PM EDTResMed (NYSE: RMD) reported Q1 EPS of $0.93, $0.06 better than the analyst estimate of $0.87. Revenue for the quarter came in at $681.1 million versus the consensus estimate of $660.66 million.
First Quarter 2020 Highlights
Revenue increased 16% to $681.1 million; up 17% on a constant currency basisGross margin expanded 120 bps... More